Clone type and case no. . | Age, y . | Sex . | L-chain . |
---|---|---|---|
Classic CLL-like (CD20low, CD23+, CD5bright, FMC7-, CD10-, IgMlow, CD79blow) | |||
1* | 70 | F | κ |
2* | 85 | F | κ |
3* | 79 | F | κ |
4 | 91 | M | κ |
5* | 68 | F | κ |
6 | 68 | M | κ |
7 | 71 | M | κ |
8 | 86 | M | κ |
9† | 76 | F | λ |
Atypical CLL-like (CD20high, CD23+, CD5bright, FMC7-, CD10-, IgMlow, CD79blow) | |||
10 | 78 | M | κ |
11 | 65 | F | κ |
12‡ | 68 | F | κ |
Non-CLL-like (CD20high, CD23-, CD5-, FMC7+, CD10-, IgM1+low, CD79b+) | |||
13§ | 78 | F | κ |
14 | 78 | F | λ |
15∥¶ | 76 | M | κ |
16¶ | 80 | M | λ |
17 | 81 | M | κ |
18# | 86 | M | κ |
19** | 74 | M | κ |
Clone type and case no. . | Age, y . | Sex . | L-chain . |
---|---|---|---|
Classic CLL-like (CD20low, CD23+, CD5bright, FMC7-, CD10-, IgMlow, CD79blow) | |||
1* | 70 | F | κ |
2* | 85 | F | κ |
3* | 79 | F | κ |
4 | 91 | M | κ |
5* | 68 | F | κ |
6 | 68 | M | κ |
7 | 71 | M | κ |
8 | 86 | M | κ |
9† | 76 | F | λ |
Atypical CLL-like (CD20high, CD23+, CD5bright, FMC7-, CD10-, IgMlow, CD79blow) | |||
10 | 78 | M | κ |
11 | 65 | F | κ |
12‡ | 68 | F | κ |
Non-CLL-like (CD20high, CD23-, CD5-, FMC7+, CD10-, IgM1+low, CD79b+) | |||
13§ | 78 | F | κ |
14 | 78 | F | λ |
15∥¶ | 76 | M | κ |
16¶ | 80 | M | λ |
17 | 81 | M | κ |
18# | 86 | M | κ |
19** | 74 | M | κ |
CD23 staining was not performed
CD10 staining was not performed
FMC7, CD10, and CD79b stainings were not performed
CD79b staining was not performed
CD23 staining was not performed
FMC7 staining was not performed
Contained a second coexisting clone, atypical CLL-like
Contained a second coexisting clone, classic CLL-like